Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Items 101–200 of 531
Rajesh, P., & Balasubramanian, K. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.025 · Cited by 74
Balakrishnan, A., Guruprasad, K. P., Satyamoorthy, K., & Joshi, M. B. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0079-7 · Cited by 80
Davegårdh, C., Broholm, C., Perfilyev, A., Henriksen, T. I., García-Calzón, S., Peijs, L., Hansen, N. S., Volkov, P., Kjøbsted, R., Wojtaszewski, J. F. P., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0792-x · Cited by 72
Self-citationZubidat, A. E., & Haim, A. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0116 · Cited by 76
Binnie, A., Walsh, C. J., Hu, P., Dwivedi, D. J., Fox‐Robichaud, A., Liaw, P. C., Tsang, J. L. Y., Batt, J. A. E., Carrasqueiro, G., Gupta, S., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004097 · Cited by 65
“sease (6), type 2 diabetes mellitus (7, 8), and asthma (9).”
Gut Microbiota Composition Is Associated with the Global DNA Methylation Pattern in Obesity
Ramos-Molina, B., Sánchez-Alcoholado, L., Cabrera-Mulero, A., Lopez-Dominguez, R., Carmona-Saez, P., Garcia-Fuentes, E., Moreno-Indias, I., & Tinahones, F. J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00613 · Cited by 64
Genomics of Islet (Dys)function and Type 2 Diabetes
Lawlor, N. T., Khetan, S., Ucar, D., & Stitzel, M. L. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.01.010 · Cited by 70
“DNA methylation studies (see Glossary) of non-diabetic (ND) and T2D islets have suggested that epigenetic dysregulation may promote T2D development [46,47].”
Mamrut, S., Avidan, N., Staun-Ram, E., Ginzburg, E., Truffault, F., Berrih‐Aknin, S., & Miller, A. (2015) · Epigenetics · doi:10.1080/15592294.2015.1084462 · Cited by 73
Nuclear factor κB–inducing kinase activation as a mechanism of pancreatic β cell failure in obesity
Malle, E. K., Zammit, N. W., Walters, S. N., Koay, Y. C., Wu, J., Tan, B. M., Villanueva, J. E., Brink, R., Loudovaris, T., Cantley, J., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150218 · Cited by 63
Bysani, M., Perfilyev, A., de Mello, V. D., Rönn, T., Nilsson, E., Pihlajamäki, J., & Ling, C. (2016) · Epigenomics · doi:10.2217/epi-2016-0087 · Cited by 75
Self-citationMcKenna, B. D., Guo, M. A., Reynolds, A. B., Hara, M., & Stein, R. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.054 · Cited by 64
Hjort, L., Jørgensen, S. W., Gillberg, L., Hall, E., Brøns, C., Frystyk, J., Vaag, A. A., & Ling, C. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0340-8 · Cited by 61
“LBW is a risk factor for complex, polygenic diseases including T2D and it is well established that numerous genes with modest effect sizes in methylation changes contribute to this disease [11, 12].”
Self-citationEvaluation of mulberry leaves’ hypoglycemic properties and hypoglycemic mechanisms
Chen, S., Xi, M., Gao, F., Li, M., Dong, T., Geng, Z., Liu, C., Huang, F., Wang, J., Li, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1045309 · Cited by 70
Epigenetic changes in diabetes
Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.046 · Cited by 58
García-Calzón, S., Perfilyev, A., Martinell, M., Ustinova, M., Kalamajski, S., Franks, P. W., Bacos, K., Elbere, I., Pihlajamäki, J., Volkov, P., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz1803 · Cited by 65
Self-citationAwamleh, Z., Butcher, D. T., Hanley, A. J., Retnakaran, R. R., Haertle, L., Haaf, T., Hamilton, J. K., & Weksberg, R. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108690 · Cited by 61
Smyth, L. J., Kilner, J., Nair, V., Liu, H., Brennan, E. P., Kerr, K., Sandholm, N., Cole, J. B., Dahlström, E. H., Syreeni, A., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01081-x · Cited by 69
CardioGxE, a catalog of gene-environment interactions for cardiometabolic traits
Parnell, L. D., Blokker, B., Dashti, H. S., Nesbeth, P.-D. C., Cooper, B. E., Ma, Y., Lee, Y., Hou, R., Lai, C., Richardson, K., et al. (2014) · BioData Mining · doi:10.1186/1756-0381-7-21 · Cited by 61
Pathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis
Al‐Khawaga, S., Memon, B., Butler, A. E., Taheri, S., Abou‐Samra, A., & Abdelalim, E. M. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12349 · Cited by 64
“The methylome of T2D islets was shown to differ from that of normal human islets, with differentially methylated genes exhibiting aberrant gene expression (Dayeh et al., 2014).”
Ishikawa, K., Tsunekawa, S., Ikeniwa, M., Izumoto, T., Iida, A., Ogata, H., Uenishi, E., Seino, Y., Ozaki, N., Sugimura, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115350 · Cited by 58
“Moreover, functional analysis demonstrated that cyclin-dependent kinase inhibitor 1A (CDKN1A) and phosphodiesterase 7B (PDE7B), which exhibit decreased DNAmethylation and increased gene expression in type 2 diabetes, result in impaired insulin secretion and exocyst complex component 3-like 2 (EXOC3L2), which exhibits…”
The Epigenomic Analysis of Human Obesity
Bell, C. G. (2017) · Obesity · doi:10.1002/oby.21909 · Cited by 66
“CpG-SNPs are proposed to play a significant facilitative epigenetic role, and these effects were recently seen be to enriched within genome-wide association study (GWAS) regions in several diseases, including type 2 diabetes (55-57).”
Yadav, D. K., Shrestha, S., Lillycrop, K. A., Joglekar, C. V., Pan, H., Holbrook, J. D., Fall, C. H. D., Yajnik, C. S., & Chandak, G. R. (2017) · Epigenomics · doi:10.2217/epi-2017-0102 · Cited by 60
Novel approaches to restore beta cell function in prediabetes and type 2 diabetes
Salunkhe, V. A., Veluthakal, R., Kahn, S. E., & Thurmond, D. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4658-3 · Cited by 65
DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
Raciti, G. A., Desiderio, A., Longo, M., Leone, A., Zatterale, F., Prevenzano, I., Miele, C., Napoli, R., & Bèguinot, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111652 · Cited by 66
“focused on pancreatic islets and analyzed DNA methylation at 479,927 CpG sites along with the transcriptome in T2D (n = 15) and non-diabetic (n = 35) donors [103].”
InfluentialDNA methylation landscapes in the pathogenesis of type 2 diabetes mellitus
Zhou, Z. G., Sun, B., Li, X., & Zhu, C. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0283-x · Cited by 70
The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans
Gerst, F., Jaghutriz, B. A., Staiger, H., Schulte, A. M., Lorza‐Gil, E., Kaiser, G., Panse, M., Haug, S., Heni, M., Schütz, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00791 · Cited by 64
Stols-Gonçalves, D., Tristão, L. S., Henneman, P., & Nieuwdorp, M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1151-4 · Cited by 55
Epigenetic Changes in Islets of Langerhans Preceding the Onset of Diabetes
Admin, A., Ouni, M., Saussenthaler, S., Eichelmann, F., Jähnert, M., Stadion, M., Wittenbecher, C., Rönn, T., Zellner, L., Gottmann, P., et al. (2020) · Diabetes · doi:10.2337/db20-0204 · Cited by 56
“Human orthologs that are covered in the 850Kmethylation array were investigated in blood cells of participants of the prospective nested case-control study (270matched pairs) for incident T2D (EPIC-Potsdam) and in islets of donors with diabetes (n 5 15) and control donors without diabetes (n 5 34) (24).”
Self-citationSchrader, S., Perfilyev, A., Ahlqvist, E., Groop, L., Vaag, A. A., Martinell, M., García-Calzón, S., & Ling, C. (2022) · Diabetes Care · doi:10.2337/dc21-2489 · Cited by 63
“We found two SIDD-MRS sites annotated to TXNIP, encoding a thioredoxin-binding protein associated with oxidative stress and regulation of b-cell function, and TXNIP methylation is associated with HbA1c and incident T2D, and is altered in muscle and islets from individuals with T2D (13,18,24,25).”
Self-citationSingh, S., Kriti, M., Anamika, K. S., Sarma, D. K., Verma, V., Nagpal, R., Mohania, D., Tiwari, R. R., & Kumar, M. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100287 · Cited by 61
“Similarly, Dayeh et al. found altered DNA methylation at CpG sites and genes, including TCF7L2, FTO, and KCNQ1, in human T2D Islets, which contribute to perturbed insulin and glucagon secretion [28].”
Yang, I. V., Zhang, W., Davidson, E. J., Fingerlin, T. E., Kechris, K., & Dabelea, D. (2018) · Diabetic Medicine · doi:10.1111/dme.13604 · Cited by 53
Bacos, K., Perfilyev, A., Karagiannopoulos, A., Cowan, E., Ofori, J. K., Bertonnier‐Brouty, L., Rönn, T., Lindqvist, A., Luan, C., Ruhrmann, S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163612 · Cited by 57
“PDE7B encodes a cAMP phosphodiesterase, which we found upregulated in T2D islets, and we previously showed that upregulation of this gene reduces GSIS (60).”
InfluentialSelf-citationRajlic, S., Treede, H., Münzel, T. F., Daiber, A., & Duerr, G. D. (2023) · Cells · doi:10.3390/cells12040583 · Cited by 57
Barajas-Olmos, F. M., Centeno-Cruz, F., Zerrweck, C., Imaz-Rosshandler, I., Martínez-Hernández, A. G., Córdova, E. J., Rangel‐Escareño, C., Faustino, G., Castillo, A., Maydón, H., et al. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0542-8 · Cited by 55
Guðmundsdóttir, V., Pedersen, H., Allebrandt, K. V., Brorsson, C., van Leeuwen, N., Banasik, K., Mahajan, A., Groves, C. J., van de Bunt, M., Dawed, A. Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189886 · Cited by 52
“Both of these pathways, in addition to the regulation of actin cytoskeleton pathway, have been implicated in type 2 diabetes, as they were found to be overrepresented among genes differentially methylated in pancreatic islets of type 2 diabetes patients compared to non-diabetic controls [30].”
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
Xiao, W., Zhou, Q., Wen, X., Wang, R., Liu, R., Wang, T., Shi, J., Hu, Y., & Hou, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702360 · Cited by 51
Epigenetic modifications and long noncoding RNAs influence pancreas development and function
Arnes, L., & Sussel, L. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.02.008 · Cited by 55
The Pancreatic Islet Regulome Browser
Mularoni, L., Ramos-Rodríguez, M., & Pasquali, L. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00013 · Cited by 54
Lemche, E., Чабан, О., & Lemche, A. V. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00142 · Cited by 56
“CpG sites of TCF7L2, FTO with differential DNA methylation in T2DM islets Bell et al., 2010; Almén et al., 2014; Dayeh et al., 2014; Rönn et al., 2015; Toperoff et al., 2015 3.1 GHRL 3p26-p25 Negative 4.1 GHSR 3q26.”
InfluentialFraszczyk, E., Luijten, M., Spijkerman, A. M. W., Snieder, H., Wackers, P. F. K., Bloks, V. W., Nicoletti, C. F., Nonino, C. B., Crujeiras, A. B., Buurman, W. A., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-019-0790-2 · Cited by 54
Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
Ramírez‐Alarcón, K., Victoriano, M., Mardones, L., Villagrán, M., Al‐Harrasi, A., Al-Rawahi, A. N., Martins, N. A., Sharifi‐Rad, J., & Martorell, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.656978 · Cited by 55
“CDKN1A overexpression decreases insulin secretion and proliferation (9) and GLRA1 silencing in clonal b-cells reduced glucosestimulated insulin secretion (10).”
The Missing lnc(RNA) between the pancreatic β-cell and diabetes
Kameswaran, V., & Kaestner, K. H. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00200 · Cited by 60
van Otterdijk, S. D., Binder, A. M., Szic, K. S. V., Schwald, J., & Michels, K. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180955 · Cited by 49
The McDonnell Genome Institute, Zou, L. S., Erdos, M. R., Taylor, D. L., Chines, P. S., Varshney, A., Parker, S. C. J., Collins, F. S., & Didion, J. P. (2018) · BMC Genomics · doi:10.1186/s12864-018-4766-y · Cited by 47
Epigenetic disturbances in obesity and diabetes: Epidemiological and functional insights
Loh, M. C. S., Zhou, L., Ng, H. K., & Chambers, J. C. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.011 · Cited by 56
“expression to result in impaired mitochondrial function and insulin secretion [90], whereby HDAC7 was one of the differentially methylated loci identified from human islet EWAS [91].”
Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
Liu, J., Lang, G.-P., & Shi, J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291932 · Cited by 55
DNA Methylation Patterning and the Regulation of Beta Cell Homeostasis
Parveen, N., & Dhawan, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651258 · Cited by 50
Yousri, N. A., Albagha, O., & Hunt, S. C. (2023) · BMC Medicine · doi:10.1186/s12916-023-03027-x · Cited by 47
The BisPCR2 method for targeted bisulfite sequencing
Bernstein, D. L., Kameswaran, V., Lay, J. E. L., Sheaffer, K. L., & Kaestner, K. H. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0020-x · Cited by 55
“We have validated the usefulness of this method in the context of type 2 diabetes, first confirming reported differences in DNA methylation at the imprinted MEG3 locus, and by validation of previous genome-wide findings of CpG risk loci identified in type 2 diabetic human islets [17, 18].”
InfluentialGlucolipotoxicity Alters Insulin Secretion via Epigenetic Changes in Human Islets
Hall, E., Jönsson, J., Ofori, J. K., Volkov, P., Perfilyev, A., Nitert, M. D., Eliasson, L., Ling, C., & Bacos, K. (2019) · Diabetes · doi:10.2337/db18-0900 · Cited by 52
“T2D when compared with methylation in islets from donors without diabetes (8,13).”
Self-citationDNA methylation in human diseases
Younesian, S., Mohammadi, M. H., Younesian, O., Momeny, M., Ghaffari, S. H., & Bashash, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32366 · Cited by 54
“Overexpression of CDKN1A , PDE7B , and SEPTIN9 in clonal β -cells of pancreatic islets due to induction of DNA hypomethylation not only halts the proliferation of these cells but also reduces their sensitivity to glucose fluctuations, leading to the lack of insulin production [123].”
DNA methylation in cardiac fibrosis: New advances and perspectives
Tao, H., Yang, J., Shi, K., Deng, Z.-Y., & Li, J. (2014) · Toxicology · doi:10.1016/j.tox.2014.07.002 · Cited by 48
Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes
Ligthart, S., Steenaard, R. V., Peters, M. J., van Meurs, J. B. J., Sijbrands, E. J. G., Uitterlinden, A. G., Bonder, M. J., Hofman, A., Franco, O. H., & Dehghan, A. (2016) · Diabetologia · doi:10.1007/s00125-016-3872-0 · Cited by 53
“pancreatic islets and adipose tissue of diabetes cases and nondiabetes controls [29, 30].”
Wu, Y., Bu, F., Yu, H., Li, W., Huang, C., Meng, X., Zhang, L., Ma, T., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.002 · Cited by 49
DNA Methylation Changes and Inflammaging in Aging-Associated Diseases
Alimohammadi, M., Makaremi, S., Rahimi, A. A. R., Asghariazar, V., Taghadosi, M., & Safarzadeh, E. (2022) · Epigenomics · doi:10.2217/epi-2022-0143 · Cited by 47
Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs
Esguerra, J., Mollet, I., Salunkhe, V., Wendt, A., & Eliasson, L. (2014) · Genes · doi:10.3390/genes5041018 · Cited by 46
“It is obvious from recent studies that epigenetic marks and miRNAs play crucial roles in the regulation of human insulin secretion [29–33].”
Self-citationPheiffer, C., Erasmus, R. T., Kengne, A. P., & Matsha, T. E. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.11.021 · Cited by 45
Mahurkar, S., Polytarchou, C., Iliopoulos, D., Pothoulakis, C., Mayer, E. A., & Chang, L. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12741 · Cited by 45
Jo, B.-S., Koh, I.-U., Bae, J.-B., Yu, H.-Y., Jeon, E., Lee, H., Kim, J.-J., Choi, M., & Choi, S. S. (2016) · Genomics · doi:10.1016/j.ygeno.2016.07.001 · Cited by 45
The Potential Use of DNA Methylation Biomarkers to Identify Risk and Progression of Type 2 Diabetes
Gillberg, L., & Ling, C. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00043 · Cited by 51
“To this end, it is noteworthy that we in a recent study identified reduced DNA methylation and increased gene expression of SEPT9 in pancreatic islets of T2D individuals compared with non-diabetic controls, supporting the role of this gene also in T2D (11).”
Self-citationDeledda, A., Palmas, V., Heidrich, V., Fosci, M., Lombardo, M., Cambarau, G., Lai, A., Melis, M., Loi, E., Loviselli, A., et al. (2022) · Metabolites · doi:10.3390/metabo12111092 · Cited by 56
“The loss of glycemic homeostasis is linked to several genetic and environmental causes; in particular, genetic [4] and epigenetic susceptibility [5] predispose to the development of T2DM, while the environmental factors are fundamental to the onset and clinical manifestations of the disease.”
Epigenetics and Type 2 Diabetes Risk
Dhawan, S., & Natarajan, R. D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1168-8 · Cited by 52
Melnik, B. C. (2021) · Biomolecules · doi:10.3390/biom11030404 · Cited by 50
Kim, K., Joyce, B. T., Zheng, Y., Schreiner, P. J., Jacobs, D. R., Catov, J. M., Shikany, J. M., Carnethon, M. R., Greenland, P., Horn, L. V., et al. (2021) · Diabetes · doi:10.2337/db20-1167 · Cited by 44
Dayeh, T., & Ling, C. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0057 · Cited by 45
“…HNF1 homeobox A (HNF1a) are often characterized by active chromatin marks (such as H3K4me3) around their promoters, lack of repressive marks (such as H3K27me3) and a low degree of DNA methylation (Yang, Dayeh et al. 2011, Yang, Dayeh et al. 2012, Hall, Dayeh et al. 2013, Pullen and Rutter 2013).”
InfluentialSelf-citationYuan, E., Yang, Y., Cheng, L. Z., Deng, X., Chen, S., Zhou, X. H., & Liu, S. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0660-y · Cited by 42
Epigenetic Mechanisms of the Aging Human Retina
Pennington, K. L., & DeAngelis, M. M. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25513 · Cited by 49
Wang, Z., Peng, H., Gao, W., Cao, W., Lv, J., Yu, C., Huang, T., Sun, D., Wang, B., Liao, C., et al. (2021) · Genomics · doi:10.1016/j.ygeno.2021.11.005 · Cited by 55
Rönn, T., Perfilyev, A., Oskolkov, N., & Ling, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-64846-3 · Cited by 44
“Additionally, several of our DNA methylation and RNA-seq data from the islets make sense “from a physiological point of view”, for example we identified increased DNA methylation and decreased expression of INS and PDX1 in islets from T2D cases versus controls 8,9,51,52 .”
Self-citationRobust validation of methylation levels association at CPT1A locus with lipid plasma levels
Gagnon, F., Aïssi, D., Carrié, A., Morange, P., & Trégouët, D. (2014) · Journal of Lipid Research · doi:10.1194/jlr.e051276 · Cited by 43
Miller, B., Petrykowska, H. M., & Elnitski, L. L. (2021) · Scientific Reports · doi:10.1038/s41598-020-80345-7 · Cited by 47
Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans
Esguerra, J. L. S., & Eliasson, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00209 · Cited by 41
Self-citationGuo, K., Elzinga, S. E., Eid, S., Figueroa‐Romero, C., Hinder, L. M., Pacut, C. M., Feldman, E. L., & Hur, J. (2019) · Epigenetics · doi:10.1080/15592294.2019.1615352 · Cited by 42
DNA methylation: a cause and consequence of type 2 diabetes
Kim, M. (2019) · Genomics & Informatics · doi:10.5808/gi.2019.17.4.e38 · Cited by 44
“Genes for which DNA methylation (and therefore expression) is altered in human T2D islets (such as CDKN1A, PDE7B, and SEPT9) contribute to the perturbation of insulin and glucagon secretion [27].”
Canivell, S., Ruano, E. G., Sisó‐Almirall, A., Kostov, B., Paz, L. G., Fernández‐Rebollo, E., Hanzu, F. A., Párrizas, M., Novials, A., & Gomis, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099310 · Cited by 43
The pancreatic β cell: recent insights from human genetics
Thomsen, S. K., & Gloyn, A. L. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.001 · Cited by 41
Divoux, A., Erdős, E., Whytock, K. L., Osborne, T. F., & Smith, S. R. (2022) · Cells · doi:10.3390/cells11050848 · Cited by 42
“Moreover, KCNQ1 hypermethylation in pancreatic beta cells was shown to associate with higher gene expression [57] and therefore decreased insulin secretion.”
Epigenetics in Precision Nutrition
Li, X., & Qi, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040533 · Cited by 43
“analyzed the DNA methylation of more than 450,000 CpG sites in pancreatic islets from 15 T2D patients and 34 non-diabetic controls [33].”
Role of DNA Methylation in Type 2 Diabetes Etiology: Using Genotype as a Causal Anchor
Elliott, H. R., Shihab, H. A., Lockett, G. A., Holloway, J. W., McRae, A. F., Smith, G. D., Ring, S. M., Gaunt, T. R., & Relton, C. L. (2017) · Diabetes · doi:10.2337/db16-0874 · Cited by 39
“For KCNQ1, there is evidence that variation in methylation potentially plays a role in type 2 diabetes, including differential methylation between type 2 diabetes case and control subjects in both adipose and pancreatic islets (11,12,45).”
Kunysz, M., Mora-Janiszewska, O., & Darmochwał-Kolarz, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094693 · Cited by 39
“SH3PXD2A hypomethylation was associated with GDM exposure in cord blood at birth [51], and with T2DM in pancreatic islets [52].”
Genetics and Epigenetics in Personalized Nutrition: Evidence, Expectations, and Experiences
Holzapfel, C., Waldenberger, M., Lorkowski, S., Daniel, H., & the Working Group “Personalized Nutrition” of the German Nutrition Society (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200077 · Cited by 42
Silencing of the FTO gene inhibits insulin secretion: An in vitro study using GRINCH cells
Taneera, J., Prasad, R. B., Dhaiban, S., Mohammed, A. K., Haataja, L., Arvan, P., Hamad, M. A., Groop, L., & Wollheim, C. B. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.06.003 · Cited by 38
Self-citationThe link among microbiota, epigenetics, and disease development
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13862-1 · Cited by 38
Diabetic Nephropathy: From Pathophysiology to Treatment
Shen, Z., Fang, Y., Xing, T., & Wang, F. (2017) · Journal of Diabetes Research · doi:10.1155/2017/2379432 · Cited by 36
GNAS gene is an important regulator of insulin secretory capacity in pancreatic β-cells
Taneera, J., Dhaiban, S., Mohammed, A. K., Mukhopadhyay, D., Aljaibeji, H., Sulaiman, N. D., Fadista, J., & Salehi, A. A. (2019) · Gene · doi:10.1016/j.gene.2019.144028 · Cited by 45
The metabolic-epigenetic nexus in type 2 diabetes mellitus
Davison, G. W., Irwin, R. E., & Walsh, C. P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.025 · Cited by 41
Implication of epigenetics in pancreas development and disease
Quilichini, E., & Haumaître, C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.10.010 · Cited by 39
FOXN3 Regulates Hepatic Glucose Utilization
Karanth, S., Zinkhan, E. K., Hill, J. T., Yost, H. J., & Schlegel, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.056 · Cited by 37
“…the most strongly associated diabetes gene TCF7L2, it is quite likely that extra-hepatic functions of FOXN3 in regulating aspects of glucose homeostasis exist (Boj et al., 2012; Dayeh et al., 2014; Grant et al., 2006; Lyssenko et al., 2007; van Es et al., 2012; van Vliet-Ostaptchouk et al., 2007).”
Ward-Caviness, C. K., Agha, G., Chen, B. H., Pfeiffer, L., Wilson, R., Petra, W., Gieger, C., Schwartz, J. D., Vokonas, P., Hou, L., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0588-7 · Cited by 39
Pathak, G. A., Silzer, T. K., Sun, J., Zhou, Z., Daniel, A. A., Johnson, L. A., O’Bryant, S. E., Phillips, N., & Barber, R. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190634 · Cited by 40
The phospholipase A2 family’s role in metabolic diseases: Focus on skeletal muscle
Cervera, I. P., Gabriel, B. M., Aldiss, P., & Morton, N. M. (2021) · Physiological Reports · doi:10.14814/phy2.14662 · Cited by 35
Chen, X., Lin, Q., Wen, J., Lin, W., Liang, J., Huang, H., Li, L., Huang, J., Chen, F., Liu, D., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13201 · Cited by 36
Mahmood, N., Arakelian, A., Cheishvili, D., Szyf, M., & Rabbani, S. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15642 · Cited by 34
Epigenetic Regulation of β Cell Identity and Dysfunction
Sun, X., Wang, L., Obayomi, S. M. B., & Wei, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725131 · Cited by 33
“In another genome-wide DNA methylation profiling using human pancreatic islets, 1,649 CpG sites and 853 genes with differential DNA methylation in pancreatic islets from type 2 diabetic donors were identified (63).”
Sandovici, I., Hammerle, C. M., Cooper, W. N., Smith, N. H., Tarry-Adkins, J. L., Dunmore, B. J., Bauer, J., Andrews, S. R., Yeo, G. S. H., Ozanne, S. E., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3837-8 · Cited by 31
“Altered DNA methylation has been reported in pancreatic islets of type 2 diabetic patients compared with non-diabetic individuals [9, 10].”
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome
Chen, Y., Wang, G., Chen, J., Wang, C., Dong, X., Chang, H., Yuan, S., Zhao, Y., & Mu, L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae002 · Cited by 41
Votsi, C., Toufexis, C., Michailidou, K., Antoniades, A., Skordis, N., Karaolis, M., Pattichis, C. S., & Christodoulou, K. (2017) · Genes · doi:10.3390/genes8010016 · Cited by 32
Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus
Hossan, T., Kundu, S., Alam, S. S., & Nagarajan, S. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190301145545 · Cited by 34
Huai, C., Wei, Y., Li, M., Zhang, X., Wu, H., Qiu, X., Shen, L., Chen, L., Zhou, W., Zhang, N., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1563 · Cited by 32
The many lives of Myc in the pancreatic β-cell
Rosselot, C., Baumel-Alterzon, S., Li, Y., Brill, G., Lambertini, L., Katz, L. S., Lu, G., García-Ocaña, A., & Scott, D. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011149 · Cited by 37
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.